SVB Leerink analyst Andrew Berens maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Outperform and raises the price target from $3 to $4.
Boeing And Disney Lead The DIA Higher Thursday
U.S. indices were trading higher Thursday amid President Joe Biden declaring that the White House had struck an infrastructure deal with a bipartisan group of senators. Investors also continue to weigh recent comments from Fed Chair Powell, who indicated inflationary pressures would abate.
